Tag Archives: Advair

FDA’s Gottlieb continues to amaze, turning agency into pharma-friendly ally.

The News: The US Food and Drug Administration on Monday (October 2, 2017) announced a series of measures designed to speed to market generic versions of complex drugs such as… Read more »

Glaxo dodges another Advair punch as second generic attempt crashes; Big Pharma’s plight highlights new world order for competition and innovation

The News: GlaxoSmithKline PLC is likely to escape generic competition to its blockbuster lung drug Advair in the US this year, after a second application for a cut-price equivalent form… Read more »

GSK Surprises Many, Names Emma Walmsley New CEO; Opinion Divided on Witty Legacy

GlaxoSmithKline PLC (London) appointed Emma Walmsley, the head of its consumer business, to become its next CEO. She is the first woman to run a major pharmaceutical giant, according to Forbes…. Read more »

Glaxo Accelerates Regulatory Plan for Triple Combo Treatment for COPD

GlaxoSmithKline PLC (London) moved to consolidate its lead in a new class of three-in-one inhaled lung drugs on Thursday with plans to file its product for U.S. approval by the… Read more »